Seeing Is Believing
Healthcare - Sector
CRSP is currently covered by 15 analysts with an average price target of $87.37. This is a potential upside of $23.38 (36.54%) from yesterday's end of day stock price of $63.99.
Crispr Therapeutics AG's activity chart (see below) currently has 344 price targets and 253 ratings on display. The stock rating distribution of CRSP is 76.19% BUY, 21.43% HOLD and 2.38% SELL.
Analysts average stock forecasts to be materialized ratio is 65.88% with an average time for these price targets to be met of 107.25 days.
Highest price target for CRSP is $105, Lowest price target is $32, average price target is $72.07.
Most recent stock forecast was given by GEOFF MEACHAM from BAML on 17-Oct-2025. First documented stock forecast 14-Nov-2016.
Currently out of the existing stock ratings of CRSP, 32 are a BUY (76.19%), 9 are a HOLD (21.43%), 1 are a SELL (2.38%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$93
$29.01 (45.34%)
$78
17 days ago
(17-Oct-2025)
2/6 (33.33%)
$23.85 (34.49%)
32
Buy
$81
$17.01 (26.58%)
$81
24 days ago
(10-Oct-2025)
8/24 (33.33%)
$7.93 (10.85%)
214
Buy
$80
$16.01 (25.02%)
$80
1 months 11 days ago
(23-Sep-2025)
4/6 (66.67%)
$19.24 (31.67%)
100
Hold
$56
$-7.99 (-12.49%)
$42
2 months 28 days ago
(06-Aug-2025)
15/18 (83.33%)
$-0.34 (-0.60%)
131
Hold
$42
$-21.99 (-34.36%)
$38
2 months 29 days ago
(05-Aug-2025)
12/14 (85.71%)
$-13.59 (-24.45%)
164
What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?
Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?
Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?